linsitinib
Showing 1 - 8 of 8
Thyroid Eye Disease, Graves Orbitopathy, Endocrine System Diseases Trial in Miami, Morgantown (linsitinib)
Recruiting
- Thyroid Eye Disease
- +11 more
- linsitinib
-
Miami, Florida
- +1 more
Oct 31, 2023
Thyroid Eye Disease, Graves Orbitopathy, Endocrine System Diseases Trial in Canada, United Kingdom, United States (Linsitinib,
Recruiting
- Thyroid Eye Disease
- +11 more
- Linsitinib
- Placebo
-
Beverly Hills, California
- +22 more
Jan 30, 2023
Relapsed Ewing Sarcoma, Refractory Ewing Sarcoma Trial in Worldwide (Linsitinib)
Completed
- Relapsed Ewing Sarcoma
- Refractory Ewing Sarcoma
- Linsitinib
-
Lyon, France
- +4 more
Feb 18, 2019
Carney Complex, Chondrosarcoma, Gastrointestinal Stromal Tumor Trial in United States (Laboratory Biomarker Analysis,
Completed
- Carney Complex
- +3 more
- Laboratory Biomarker Analysis
- +2 more
-
Palo Alto, California
- +7 more
Aug 23, 2018
Advanced Solid Tumors Trial in Worldwide (linsitinib, erlotinib, paclitaxel)
Completed
- Advanced Solid Tumors
- linsitinib
- +4 more
-
La Jolla, California
- +11 more
Aug 30, 2018
Recurrent Small Cell Lung Carcinoma Trial in Singapore, United States (Laboratory Biomarker Analysis, Linsitinib,
Completed
- Recurrent Small Cell Lung Carcinoma
- Laboratory Biomarker Analysis
- +3 more
-
Scottsdale, Arizona
- +10 more
Dec 10, 2015
Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Cleveland (linsitinib,
Completed
- Adenocarcinoma of the Prostate
- +3 more
- linsitinib
- laboratory biomarker analysis
-
Cleveland, Ohio
- +1 more
Mar 2, 2015
Recurrent Skin Cancer, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Squamous Cell Carcinoma of the Skin Trial
Withdrawn
- Recurrent Skin Cancer
- +5 more
- erlotinib hydrochloride
- +5 more
-
Portland, OregonOHSU Knight Cancer Institute
Nov 17, 2014